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Abstract
Underlying biochemical factors that contribute towards the preparedness for labour and ripening of the cervix remain largely 
unknown. We aimed to characterize metabolic and hormonal determinants that constitute the preparedness for labour in women.
The aim of the research was to study the content of relaxin and amino acids involved in its formation in primiparous preg-
nant women with various degrees of birth preparedness.
Materials and methods: Prospective study has been conducted on 115 primiparous women at 38–40 weeks of gestation. Bio-
chemical methods were used to analyse relaxin and amino acid levels in pregnant women with varying degree of birth preparedness. 
Results: the obtained data from the study indicate importance role of relaxin in the underlying pathogenesis in women with 
variable degree of preparedness for labour. The results allow to use the levels of relaxin serum as a predictor of the state of the birth 
canal. Furthermore, the amino acids are known to participate in various critical metabolic processes and play an important role is 
orchestrating many essential pathways in the body. We present the analysis of amino acids involved in the formation of relaxin in the 
serum of pregnant women. Our analysis has shown that amino acid imbalance leads to disruption of energy metabolism and blood 
flow rate, resulting in metabolic, structural and functional changes in the cervix at the onset of labour. 
Conclusion: considering the mechanisms of the possible influence of relaxin and amino acids on the cervical ripening, we 
concluded that correcting amino acid imbalance and normalising relaxin levels should be included in preinduction of labour thera-
peutic regimen. This would be an important step in improving the perinatal outcomes.
Keywords: labor induction, relaxin, cervical ripening, amino acids imbalance.
DOI: 10.21303/2504-5679.2021.001683
1. Introduction
Abnormal labour is a major problem in obstetrics and neonatology, which making increas-
ingly significant contributions to maternal morbidity. The body’s birth preparedness is determined 
by a number of signs, the appearance of which indicates the possibility of a spontaneous labor 
onset [1, 2]. With better understanding of normal and abnormal parturition we may be able to un-
derstand the critical role of endocrine-immune interaction in the process of labour. The main test 
of the birth canal maturity is considered to be the morpho-functional assessment of the uterine 
readiness for childbirth [3, 4].
Preparedness for the onset of labour affects the complications that pregnant women, foetus 
and new-born experience and it remains an important focus of research in modern obstetrics and 
gynecology [5, 6].
Literature review has shown that previous studies have focused largely on the positive and 
negative pregnancy outcomes in women suffering from gestation complications displayed in their 
obstetrics and gynaecology medical history [7, 8]. The underlying causes of lack of preparedness 
for the onset of labour in women in their first pregnancy remains unknown. Considering the medi-
cal, social and demographic importance of safe labour in women in their first pregnancy, this study 
focuses on understanding the pathological criteria of cervix ripening [9, 10].
Recent studies have drawn much attention to the hormone relaxin, which is considered as 
a predictor of pathological labour [11].
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Relaxin is a polypeptide hormone with a molecular weight of 5–6 kDa belongs to the IGF 
family of hormones (insulin-like growth factor). It consists of two peptide chains A and B linked by 
disulphide bridges. The relaxin chain has 22 amino acid residues, and the B chain has 30 amino acid 
residues. Relaxin is an important participant in many biological processes at all stages of pregnancy. 
Moreover, both its deficiency and excess can have negative consequences for pregnancy [12, 13].
In obstetrics relaxin is involved in the pathogenesis of abortion [14]. In addition, in the late sta-
ges of gestation, relaxin promotes uterine maturity by regulating the sequential processes of collagen 
degradation and remodelling, causes relaxation of the ligaments of the pubic joint of the pelvic bones, 
thus carrying out optimal preparation of the maternal organism for physiological childbirth [15, 16].
The amino acids involved in the formation of relaxin include: alanine, aspartic, cysteic and 
glutamic acids, glycine, histidine, tyrosine, and valine. Amino acids, due to their chemical struc-
ture (the presence of carboxy and amino groups), participate in the regulation of many reactions, 
having their own specifics, which determines different direction of their effects. However, the num-
ber of studies researching the content of amino acids in the blood of women during pregnancy, es-
pecially before labour, is insignificant [17]. Thus, the question of the informativeness of changes in 
the level of individual amino acids in the body, their importance for the regulation of physiological 
body preparedness for childbirth, diagnosis, as well as metabolic correction of amino acid imbalance 
remains practically unresolved [18, 19].
The aim of the research was to study the content of relaxin and amino acids involved in its 
formation in primiparous pregnant women with various degrees of birth preparedness.
2. Materials and methods
All experiments were conducted between 2019–2020 at the clinical bases of the Department 
of Obstetrics and Gynecology No. 1, Kharkiv National Medical University, Kharkiv, Ukraine. 
Prospective study has been conducted on 115 primiparous women at 38–40 weeks of gestation. 
Depending on the degree of uterine birth preparedness, the examined were divided into two groups. 
The degree of the uterine birth preparedness was assessed using the E. H. Bishop scale. Group I (con-
trol) consisted of 40 (34.8 %) primiparous pregnant women with a mature uterine (9–13 points); 
Group II (main) included 75 (65.2 %) women with immature uterine (0–5 points).
The criteria for including patients in the study groups were: the first pregnancy at 
38–40 weeks, the absence of severe extragenital pathology, and the absence of late gestosis.
The criteria for excluding from the observation group were: repeated pregnancy and child-
birth, pregnancy occurred as a result of assisted reproductive technologies, women who had indi-
cations for planned delivery by cesarean section, acute and exacerbation of chronic inflammatory 
diseases, severe extragenital pathology, and late gestosis.
Ethical approval was obtained from the Bioethics committee of Kharkiv National Medical 
University (protocol No. 2, 10.06.2020). All participants consented to take part in the study. All 
experiments involving participants were conducted in accordance with World Medical Association 
Declaration of Helsinki. 
Experimental procedures. The peripheral venous blood was the study material. The con-
tent of relaxin in the blood was determined by the enzyme-linked immunosorbent assay using the 
Human RLN2 ELISA kit (Elabsience, USA).
The content of free amino acids was determined according to the standard method [20] on 
an LC5001 amino acid analyzer from Biotronic (Germany).
Statistical processing of the obtained data was carried out by the methods of variational 
analysis using the Student’s t-test.
3. Research results
Most of the women in the control group were between the ages of 21–25 (40.0 %). The largest 
number of women aged 31 to 35 years was in the main group (30.7 %). There were 8 (20.0 %) and 
12 (16.0 %) pregnant women at the age of 26–30 years in the control and main group, respectively.
In general, a high frequency of gynecological diseases was revealed in the examined groups. 
It should be noted that in the group of women with mature uterine (control group), the frequency of 
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these diseases was 2.2 times lower than in the main group (p < 0.05). The structure of gynecologi-
cal morbidity was represented mainly by diseases of the cervix, chronic inflammatory diseases of 
the uterine appendages and abnormal uterine bleeding. 13 (32.5 %) pregnant women in the control 
group and 15 (20.0 %) pregnant women in the main group were gynecologically healthy. The inci-
dence of cervical pathology in the control group was 37.5 % and 46.7 % in the main group. Inflam-
matory diseases of the genitals were observed in 15.0 % of pregnant women in the control group 
and in 60.0 % of women in the main group. Abnormal uterine bleeding was twice as common in 
pregnant women of the main group. Benign diseases of the uterine appendages were found in 5.0 % 
and 8.0 % in control and main groups, respectively.
Undoubtedly, extragenital pathology had a significant effect on the course of the gestational 
process, the preparation of the body for childbirth.
When examining the medical records of pregnant women, we paid attention to a high fre-
quency of concomitant extragenital pathology. In the structure of diseases the following prevailed: 
respiratory diseases in 32.5 % (control group), and 40.0 % (main group) of women; neurocircula-
tory dystonia in 27.5 % and 29.3 % of pregnant women in the control and main groups; diseases 
of the urinary system, mainly chronic pyelonephritis in 10.0 % and 24.0 % of pregnant women in 
the control and main groups; diseases of the gastrointestinal tract in 7.5 % and 21.3 % of women 
in the control and main groups; diseases of the thyroid gland in 5.0 % and 28.0 % of pregnant 
women in the control and main groups. Since thyroid hormones increase the sensitivity of the 
ovaries to gonadotropic hormones and the endometrium to estrogens, together with thyroid hor-
mones deficiency, there occurs estrogen metabolism change and disruption of the process of birth 
preparedness [21].
The hypertensive type prevailed among the main group patients with neurocirculatory dys-
tonia, which indicated dysregulation of the cardiovascular system. There were 17 (56.7%) soma-
tically healthy women in the control group and 19 (25.3 %) in the main group. 16 (53.3 %) of the 
examined pregnant women in the control group and 35 (46.7 %) in the main group had childhood 
infections (measles, rubella, chickenpox) which was proved by their medical records.
Estimating the body mass index in pregnant women at the time of admission according to the 
formula BMI = weight (kg) / height2 (m). It was found that 5 (12.5 %) pregnant women in the control 
group and 8 (10.7 %) women the main group had obesity. A combination of factors such as first child-
birth, BMI ≥ 30.1 can be risk factors for insufficient preparation of a woman’s body for childbirth.
Thus, a high frequency of gynecological diseases, extragenital pathology, overweight in 
women of the study groups, as a manifestation of dysfunction of the central regulatory link, can 
adversely affect the uterine maturity, and are also regarded as risk factors in assessing the degree 
of body birth preparedness.
The study of the relaxin concentration showed that women with immature uterine had low 
values of this hormone (208.9 ± 27.6 pg/ml) in the blood serum, compared with similar indicators 
in the control group (361.8 ± 38.4 pg/ml), p ˂ 0.05. It can be assumed that the low level of relaxin in 
the group of pregnant women with immature uterine inhibited the process of cervical dilatation. 
Considering the mechanisms of the possible influence of relaxin on the state of the birth canal 
readiness, one can note its ability to change the activity of matrix metalloproteinases that control 
the structure of glycoproteins in the extracellular matrix [8, 13, 15].
The analysis of amino acids involved in the formation of relaxin in the blood serum of preg-
nant women of groups I and II is presented in Table 1.
When analyzing the above data, we noted the increased amount of aspartic acid in the main 
group. This acid plays an important role in nitrogen metabolism. Glutamic acid, which is involved 
in energy metabolism, was also detected in an increased amount. Since these amino acids inter-
connect nitrogen and energy metabolism, a change in their level affects the state of metabolism in 
cells and tissues.
A 1.7-fold decrease in the content of cysteine was found in the main group of pregnant 
women in comparison with the control group. This amino acid with metabolic functions is involved 









The levels of amino acids in the blood serum of the examined pregnant women (mg/l)
Amino acid
Study groups
Group I (control, n = 40) Group ІІ (main, n = 75)
Aspartic acid 14.2 ± 1.2 18.7 ± 1.9*







Note: * р˂0.05 – statistical significance of differences between indicators of groups I and II
The histidine content was increased in the main group by 24 %. An increase in histidine 
content inhibits pH-dependent and pH-independent transport of a number of neutral amino acids. 
In addition, an increase in the amount of histidine may be accompanied by an increase in the 
production of histamine, which has vasoconstrictor properties and, therefore, impairs blood flow. 
As a result, tissue hypoxia occurs.
A significant increase in the aromatic amino acid tyrosine in the main group indicates the 
activity of energy and metabolic processes in the cell membranes. At the same time, the obtained 
results showed the depletion of the glycine fund, the main sulfur-containing amino acid having 
neurotransmitter and immunomodulatory effects.
4. Discussion
Assessment of cervical ripening and preparedness for labour is instrumental in safe preg-
nancy and labour. It is therefore important to understand key biological and biochemical determi-
nants that would serve as an effective readout for the assessment of the preparedness for labour. 
Previous studies have implicated relaxin as an important factor in predicting delivery in 
high-risk pregnancies [22]. Furthermore, relaxin has been shown to facilitate cervical ripening 
and trigger parturition [23]. Of note, exogenous relaxin has also been trialled to treat a number of 
health conditions including heart failure [24] suggesting that relaxin therapy is safe and may be 
used in synergy in high risk patients during pregnancy. Our work was focused on understanding 
the levels of relaxin in women with different preparedness for labour and whether these levels 
could be used to assess the reediness for the onset of labour. Our data clearly demonstrates that 
relaxin is an effective tool is assessing the state of the uterus in preparation for labour and there-
fore serves as an indicator for the preinduction of labour and can potentially be modulated using 
targeted therapies. 
In addition to relaxin levels, the presence of gynecological diseases in our study groups 
had an effect on gestation process. However, biochemical analysis of the impact of individual pa-
thologies associated with gynecological diseases on the relaxin levels was beyond the scope of 
this study. Future research could explore whether any secondary health conditions associated with 
specific gynecological pathologies have an additional effect on relaxin levels. 
Current work in our department is focusing on understanding the molecular basis of the 
effect of relaxin on the host cells. Understanding the intracellular signalling cascade that relaxin 
triggers in the uterus at different stages during pregnancy will illuminate further the role of this 
multifunctional molecule in determining pregnancy outcomes. 
Amino acids are essential building blocks of life. The role of amino acids in protein synthe-
sis, metabolism, signalling, immune response has extensively been covered in literature. Previous 
studies have identified the role of several amino acids in pregnancy outcomes. For example, the 
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development of pathologies, such as pre-eclampsia and placental dysfunction, is often accompa-
nied by changes in the amino acids levels, which in turn affects the course of effective adaptation 
to pregnancy [25, 26]. Here we asked a question whether amino acids essential for the synthesis 
of relaxin may be involved in determining the outcome of pregnancy. Our work demonstrates that 
limited or excessive levels of cystine and aspartic acid, histidine and tyrosine respectively were 
linked to a number of negative outcomes in women with variable degree of labour preparedness. 
Study limitations. The study involved a small number of patients. Future studies will be-
nefit from expanding the number of patients in both study and control groups. 
The work presented here did not conduct follow up post-partum analysis of women involved 
in the study. 
Prospects for further research. Future work will focus on understanding whether there is 
a link between the diet, which is the direct source of the amino acids, and amino acid levels in 
women with different preparedness for labour. Furthermore, we would like to investigate the ex-
pression levels of different core enzymes involved in amino acid metabolism at the genetic level. 
This will reveal the amino acid requirements of the host at different stages of gestation and serve 
as an atlas of amino acid metabolism during pregnancy.
Future work serves an important basis for designing novel therapeutic interventions to tar-
get relaxin and amino acids levels to prevent negative perinatal outcomes. 
5. Conclusions
1. A 43 % drop in relaxin levels was observed in women with immature uterine compared 
to control group. This implicates relaxin in the pathogenesis in women with variable degree of pre-
paredness for labour. This observation allows to consider the serum levels of relaxin as a predictor 
of the biological birth preparedness of the body.
2. We noted a significant amino acid imbalance in the studied patients, in particular in 
amino acids associates with production of relaxin. Since amino acids play an important role in ho-
meostasis including energy metabolism and blood flow rate, our results suggesting that disruption 
of amino acid balance may in turn lead to structural and functional changes in the cervix.
3. The analysis presented here suggests the need to use agents that modulate relaxin levels 
during the pre-induction labour and correct amino acid imbalance during preparation for labour.
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